Benefit of prophylactic anticoagulation before and during first-line chemotherapy on patients with metastatic germ cell tumors.

Christian Daniel Fankhauser,Ben Tran,José Manuel Ruiz-Morales,Enrique Gonzalez-Billalabeitia,Christoph Seidel,Carsten Bokemeyer,Thomas Hermanns,Alexey Rumyantsev,Margarida Brito Goncalves,Aude Flechon,Edmond M. Kwan,Daniel Castellano,Xavier Garcia-del-Muro,Anis Hamid,Margaret Ottaviano,Alison Reid,Philippe L. Bedard,Christopher Sweeney,Jean M. Connors

Benefit of prophylactic anticoagulation before and during first-line chemotherapy on patients with metastatic germ cell tumors.

2020

Christian Daniel Fankhauser
Ben Tran
José Manuel Ruiz-Morales
Enrique Gonzalez-Billalabeitia
Christoph Seidel
Carsten Bokemeyer
Thomas Hermanns
Alexey Rumyantsev
Margarida Brito Goncalves
Aude Flechon
Edmond M. Kwan
Daniel Castellano
Xavier Garcia-del-Muro
Anis Hamid
Margaret Ottaviano
Alison Reid
Philippe L. Bedard
Christopher Sweeney
Jean M. Connors

402Background: Recent trials randomising patients (pts) receiving systemic cancer therapy showed that prophylactic anticoagulation (PAK) halves the risk of venous thromboembolic events (VTE) and do...

Keywords:

Germ cell tumors
Oncology
Pathology
Internal medicine
Chemotherapy
first line
Medicine
cancer therapy
first line chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations